Dr. Matthew G Davis, MD
Claim this profileGSK Investigational Site
Affiliated Hospitals
Rochester Clinical Research, Inc
Rochester Clinical Research
Clinical Trials Matthew G Davis, MD is currently running
New Vaccine
for Flu
The aim of this study is to evaluate the safety, reactogenicity and immunogenicity of the Flu Pandemic messenger RNA (mRNA) vaccine (including dose-finding and dose-confirmation) administered in healthy adults 18 to 85 years of age.
Recruiting
0 awards
Phase 1 & 2
3 criteria
RSV Vaccine
for Adults 60+
The purpose of this study is: * To investigate the optimal timing for revaccination after the initial RSVPreF3 OA vaccine dose, * To evaluate the long-term immune persistence and safety up to 5 consecutive RSV seasons (approximately 60 months) of a single dose of RSVPreF3 OA vaccine, * To give the opportunity to participants who received only placebo in the RSVOA=ADJ- 006 study, to receive a dose of the RSVPreF3 OA vaccine and collect additional safety information.
Recruiting
2 awards
Phase 3
1 criteria
More about Matthew G Davis, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Matthew G Davis, MD has experience with
- PXVX0317
- RSVPreF3 OA Vaccine
- Placebo
- RSVPreF3 OA Investigational Vaccine
- Bivalent GII.4/GI.1 Vaccine
- 24 Valent Pneumococcal Conjugate Vaccine
Breakdown of trials Matthew G Davis, MD has run
Respiratory Syncytial Virus Infection
Respiratory Syncytial Virus
I Am A Healthy Volunteer
Coronavirus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew G Davis, MD specialize in?
Matthew G Davis, MD focuses on Respiratory Syncytial Virus Infection and Respiratory Syncytial Virus. In particular, much of their work with Respiratory Syncytial Virus Infection has involved treating patients, or patients who are undergoing treatment.
Is Matthew G Davis, MD currently recruiting for clinical trials?
Yes, Matthew G Davis, MD is currently recruiting for 2 clinical trials in Rochester New York. If you're interested in participating, you should apply.
Are there any treatments that Matthew G Davis, MD has studied deeply?
Yes, Matthew G Davis, MD has studied treatments such as PXVX0317, RSVPreF3 OA vaccine, Placebo.
What is the best way to schedule an appointment with Matthew G Davis, MD?
Apply for one of the trials that Matthew G Davis, MD is conducting.
What is the office address of Matthew G Davis, MD?
The office of Matthew G Davis, MD is located at: GSK Investigational Site, Rochester, New York 14609 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.